Livingstone-Banks Jonathan, Lindson Nicola, Hartmann-Boyce Jamie
Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.
Department of Health Promotion and Policy, University of Massachusetts Amherst, Amherst, MA, USA.
Addiction. 2024 Dec;119(12):2101-2115. doi: 10.1111/add.16624. Epub 2024 Sep 4.
To summarise systematic reviews on tobacco addiction published by the Cochrane Tobacco Addiction Group (CTAG) from 2021 to 2023.
We identified all new and updated Cochrane Reviews published by CTAG between 2021 and 2023. We present key results from these reviews and discuss promising avenues for future research.
CTAG published five new reviews and one overview of reviews, and updated eight reviews. Review evidence showed that all main pharmacotherapies (varenicline, cytisine, bupropion and nicotine replacement therapy [NRT], especially when patches are combined with fast acting forms like gum) are effective for smoking cessation, as are nicotine e-cigarettes. Evidence suggested similar magnitude of effects of varenicline, cytisine, and nicotine e-cigarettes; these emerged as the most effective treatments. Evidence also supported behavioural counselling and financial incentives for smoking cessation. Secondary analyses of the Cochrane review of e-cigarettes for smoking cessation showed over half of participants assigned to e-cigarette conditions were still using them at six months or longer, that biomarkers of potential harm significantly reduced in people switching from smoking to vaping or to dual use, and that there was insufficient evidence to draw associations between e-liquid flavours and smoking cessation. Findings on mindfulness-based interventions, interventions delivered by dental and primary care professionals, interventions to prevent weight gain after smoking cessation, and interventions for waterpipe cessation were less certain. Reviews of observational evidence showed that smoking cessation reduced cardiovascular events and mortality in people living with cardiovascular disease, and improved mental health.
Nicotine replacement therapy (especially patches combined with fast acting forms), varenicline, cytisine, bupropion, nicotine e-cigarettes, behavioural counselling, and financial incentives are all effective ways to help people quit smoking. Quitting smoking improves mental health and reduces cardiovascular events and mortality in people living with cardiovascular disease.
总结Cochrane烟草成瘾小组(CTAG)在2021年至2023年期间发表的关于烟草成瘾的系统评价。
我们识别了CTAG在2021年至2023年期间发表的所有新的和更新的Cochrane系统评价。我们展示了这些评价的关键结果,并讨论了未来研究的有前景的途径。
CTAG发表了五项新的评价和一项评价概述,并更新了八项评价。评价证据表明,所有主要的药物治疗方法(伐尼克兰、金雀花碱、安非他酮和尼古丁替代疗法[NRT],特别是当贴片与口香糖等速效形式联合使用时)以及尼古丁电子烟对戒烟均有效。证据表明,伐尼克兰、金雀花碱和尼古丁电子烟的效果程度相似;这些是最有效的治疗方法。证据还支持行为咨询和戒烟的经济激励措施。对Cochrane关于电子烟戒烟评价的二次分析表明,超过一半被分配到电子烟组的参与者在六个月或更长时间仍在使用电子烟,从吸烟转向吸电子烟或同时使用两种方式的人潜在危害的生物标志物显著降低,并且没有足够的证据得出电子烟液口味与戒烟之间的关联。基于正念的干预措施、牙科和初级保健专业人员实施的干预措施、预防戒烟后体重增加的干预措施以及水烟戒烟干预措施的研究结果不太确定。观察性证据的评价表明,戒烟可降低心血管疾病患者的心血管事件和死亡率,并改善心理健康。
尼古丁替代疗法(特别是贴片与速效形式联合使用)、伐尼克兰、金雀花碱、安非他酮、尼古丁电子烟、行为咨询和经济激励都是帮助人们戒烟的有效方法。戒烟可改善心理健康,并降低心血管疾病患者的心血管事件和死亡率。